
A study analyzed the clinical characteristics and genetic testing of 28 pediatric restrictive cardiomyopathy patients. The median age at diagnosis was 6 years. Half of the patients had pathologic or likely-pathogenic gene variants, with TNNI3 missense variants being the most common. No significant differences in clinical manifestations were found between patients with positive and negative pathogenic variants. However, patients with pathogenic variants had significantly lower survival rates than those without, particularly at 2- and 5-year intervals. Patients diagnosed through school screenings had better transplant-free survival compared to those diagnosed based on heart failure symptoms.
Like
Save
Share